Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is applied in patients with advanced neuroendocrine tumors. Co-infused amino acids (AA) should prevent nephrotoxicity. The aims of this study were to correlate the incidence of AA-induced hyperkalemia (HK) (≥5.0 mmol/l) and to identify predict...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EJNMMI Res
Main Authors: Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lueckerath, Katharina, Muegge, Dirk O, Strate, Alexander, Haenscheid, Heribert, Schirbel, Andreas, Allen-Auerbach, Martin S, Bundschuh, Ralph A, Buck, Andreas K, Herrmann, Ken
Formato: Artigo
Idioma:Inglês
Publicado: Springer 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412196/
https://ncbi.nlm.nih.gov/pubmed/25977880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0074-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares